Literature DB >> 15247414

Varicella-zoster virus infection of human neural cells in vivo.

Armin Baiker1, Klaus Fabel, Antonio Cozzio, Leigh Zerboni, Konstanze Fabel, Marvin Sommer, Nobuko Uchida, Dongping He, Irving Weissman, Ann M Arvin.   

Abstract

Varicella-zoster virus (VZV) establishes latency in sensory ganglia and causes herpes zoster upon reactivation. These investigations in a nonobese diabetic severe combined immunodeficient mouse-human neural cell model showed that VZV infected both neurons and glial cells and spread efficiently from cell to cell in vivo. Neural cell morphology and protein synthesis were preserved, in contrast to destruction of epithelial cells by VZV. Expression of VZV genes in neural cells was characterized by nuclear retention of the major viral transactivating protein and a block in synthesis of the predominant envelope glycoprotein. The attenuated VZV vaccine strain retained infectivity for neurons and glial cells in vivo. VZV gene expression in differentiated human neural cells in vivo differs from neural infection by herpes simplex virus, which is characterized by latency-associated transcripts, and from lytic VZV replication in skin. The chimeric nonobese diabetic severe combined immunodeficient mouse model may be useful for investigating other neurotropic human viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247414      PMCID: PMC490013          DOI: 10.1073/pnas.0404016101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Direct isolation of human central nervous system stem cells.

Authors:  N Uchida; D W Buck; D He; M J Reitsma; M Masek; T V Phan; A S Tsukamoto; F H Gage; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Neurologic complications of the reactivation of varicella-zoster virus.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; J J LaGuardia; R Mahalingam; R J Cohrs
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

3.  Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; S Bontems; C Sadzot-Delvaux
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

4.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.

Authors:  S R Pevenstein; R K Williams; D McChesney; E K Mont; J E Smialek; S E Straus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.

Authors:  M H Sommer; E Zagha; O K Serrano; C C Ku; L Zerboni; A Baiker; R Santos; M Spengler; J Lynch; C Grose; W Ruyechan; J Hay; A M Arvin
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.

Authors:  Y Gomi; T Imagawa; M Takahashi; K Yamanishi
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

8.  Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63.

Authors:  T K Kenyon; J Lynch; J Hay; W Ruyechan; C Grose
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation.

Authors:  A L Vescovi; E A Parati; A Gritti; P Poulin; M Ferrario; E Wanke; P Frölichsthal-Schoeller; L Cova; M Arcellana-Panlilio; A Colombo; R Galli
Journal:  Exp Neurol       Date:  1999-03       Impact factor: 5.330

10.  Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

Authors:  B L Davidson; C S Stein; J A Heth; I Martins; R M Kotin; T A Derksen; J Zabner; A Ghodsi; J A Chiorini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  15 in total

1.  Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.

Authors:  Chantelle Hood; Anthony L Cunningham; Barry Slobedman; Ann M Arvin; Marvin H Sommer; Paul R Kinchington; Allison Abendroth
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Authors:  Seung-Tae Lee; Paige Bracci; Mi Zhou; Terri Rice; John Wiencke; Margaret Wrensch; Joseph Wiemels
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

3.  Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology.

Authors:  Amy C Keller; Hussain Badani; P Mason McClatchey; Nicholas L Baird; Jacqueline L Bowlin; Ron Bouchard; Guey-Chuen Perng; Jane E B Reusch; Benedikt B Kaufer; Don Gilden; Aamir Shahzad; Peter G E Kennedy; Randall J Cohrs
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

4.  Productive varicella-zoster virus infection of cultured intact human ganglia.

Authors:  Kavitha Gowrishankar; Barry Slobedman; Anthony L Cunningham; Monica Miranda-Saksena; Ross A Boadle; Allison Abendroth
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Varicella-zoster virus infection of human dorsal root ganglia in vivo.

Authors:  Leigh Zerboni; Chia-Chi Ku; Carol D Jones; James L Zehnder; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

6.  Varicella-zoster virus infection of differentiated human neural stem cells.

Authors:  Subbiah Pugazhenthi; Sreekala Nair; Kalpana Velmurugan; Qiaoling Liang; Ravi Mahalingam; Randall J Cohrs; Maria A Nagel; Don Gilden
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Virus infection, antiviral immunity, and autoimmunity.

Authors:  Daniel R Getts; Emily M L Chastain; Rachael L Terry; Stephen D Miller
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 9.  Varicella zoster virus (VZV)-human neuron interaction.

Authors:  Nicholas L Baird; Xiaoli Yu; Randall J Cohrs; Don Gilden
Journal:  Viruses       Date:  2013-09-04       Impact factor: 5.048

10.  Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection.

Authors:  Katherine S Lee; Wenbo Zhou; Jonah J Scott-McKean; Kaitlin L Emmerling; Guang-yun Cai; David L Krah; Alberto C Costa; Curt R Freed; Myron J Levin
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.